|
Neuroprotectors
Citations 1-10 of 531 total displayed.
|
Most recent content
(12 Nov 2009):
|
- Articles
Neuroprotection Against Hypoxic-Ischemic Brain Injury by Inhibiting the Apoptotic Protease Activating Factor-1 Pathway
- Yanqin Gao, Weimin Liang, Xiaoming Hu, Wenting Zhang, R. Anne Stetler, Peter Vosler, Guodong Cao, and Jun Chen
Stroke published November 12, 2009, doi:10.1161/STROKEAHA.109.561852
[Abstract]
|
Past content
(since Jan 1999):
|
- Articles
Brain Ischemic Preconditioning Does Not Require PARP-1
- Giuseppe Faraco, Francesco Blasi, Wookee Min, Zhao-Qi Wang, Flavio Moroni, and Alberto Chiarugi
Stroke published November 5, 2009, doi:10.1161/STROKEAHA.109.567826
[Abstract]
- Original Contributions
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Effects of a Targeted Exposure of Intravenous Repinotan in Patients With Acute Ischemic Stroke: Modified Randomized Exposure Controlled Trial (mRECT)
- Philip Teal, Stephen Davis, Werner Hacke, Markku Kaste, Patrick D. Lyden, for the mRECT Study Investigators, Monika Fierus, and for Bayer HealthCare AG
Stroke 2009;40:3518-3525; published online before print as doi:10.1161/STROKEAHA.109.551382
[Abstract]
[Full text]
- Articles
Caspase-1 Inhibitor Prevents Neurogenic Pulmonary Edema After Subarachnoid Hemorrhage in Mice
- Hidenori Suzuki, Takumi Sozen, Yu Hasegawa, Wanqiu Chen, and John H. Zhang
Stroke published October 29, 2009, doi:10.1161/STROKEAHA.109.566109
[Abstract]
- Articles
Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke
- Hannelore Ehrenreich, Karin Weissenborn, Hilmar Prange, Dietmar Schneider, Christian Weimar, Katja Wartenberg, Peter D. Schellinger, Matthias Bohn, Harald Becker, Martin Wegrzyn, Peter Jähnig, Manfred Herrmann, Michael Knauth, Mathias Bähr, Wolfgang Heide, Armin Wagner, Stefan Schwab, Heinz Reichmann, Günther Schwendemann, Reinhard Dengler, Andreas Kastrup, Claudia Bartels for the EPO Stroke Trial Group
Stroke published October 15, 2009, doi:10.1161/STROKEAHA.109.564872
[Abstract]
- Comments, Opinions, and Review
Pharmacologic Interventions for Stroke: Looking Beyond the Thrombolysis Time Window Into the Penumbra With Biomarkers, Not a Stopwatch
- Juan C. Chavez, Orest Hurko, Frank C. Barone, and Giora Z. Feuerstein
Stroke 2009;40:e558-563e; published online before print as doi:10.1161/STROKEAHA.109.559914
[Abstract]
[Full text]
- Original Contributions
Hypoxic Preconditioning-Induced Cerebral Ischemic Tolerance: Role of Microvascular Sphingosine Kinase 2
- Bradley K. Wacker, Tae Sung Park, and Jeffrey M. Gidday
Stroke 2009;40:3342-3348; published online before print as doi:10.1161/STROKEAHA.109.560714
[Abstract]
[Full text]
- Original Contributions
Delayed Hypoxic Postconditioning Protects Against Cerebral Ischemia in the Mouse
- Claire Leconte, Emmanuelle Tixier, Thomas Freret, Jérôme Toutain, Romaric Saulnier, Michel Boulouard, Simon Roussel, Pascale Schumann-Bard, and Myriam Bernaudin
Stroke 2009;40:3349-3355; published online before print as doi:10.1161/STROKEAHA.109.557314
[Abstract]
[Full text]
- Original Contributions
Intense Correlation Between Brain Infarction and Protein-Conjugated Acrolein
- Ryotaro Saiki, Kazuhiro Nishimura, Itsuko Ishii, Tomohiro Omura, Shigeru Okuyama, Keiko Kashiwagi, and Kazuei Igarashi
Stroke 2009;40:3356-3361; published online before print as doi:10.1161/STROKEAHA.109.553248
[Abstract]
[Full text]
- Original Contributions
Alternate Pathways Preserve Tumor Necrosis Factor- Production After Nuclear Factor- B Inhibition in Neonatal Cerebral Hypoxia–Ischemia
- Cora H. Nijboer, Cobi J. Heijnen, Floris Groenendaal, Frank van Bel, and Annemieke Kavelaars
Stroke 2009;40:3362-3368; published online before print as doi:10.1161/STROKEAHA.109.560250
[Abstract]
[Full text]
|
|
